Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors

Molecular Endocrinology

Volumn 17, Issue 1, 2003, Pages 79-92

  Nygård, Maria ^a   Wahlström, Gunilla M ^a   Gustafsson, Maria V ^a   Tokumoto, Yasuhito M ^b   Bondesson, Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; LIGAND; MESSENGER RNA; THYMIDINE KINASE; THYROID HORMONE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CARCINOMA, EMBRYONAL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; MICE; OLIGODENDROGLIA; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; STEM CELLS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRIIODOTHYRONINE; TUMOR CELLS, CULTURED;

AMPHIBIA; ANIMALIA; AVES; MAMMALIA;

EID: 0346665563     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0107     Document Type: Article

References (95)

1. Chan S, Kilby MD 2000 Thyroid hormone and the central nervous system development. J Endocrinol 165:1-8
2. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
3. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
4. 3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825
5. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
6. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN 1997 Histone deacetylases associated with the mSin3 co-repressor mediate mad transcriptional repression. Cell 89:349-356
7. Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J 2000 Both co-repressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19:4342-4350
8. Wen YD, Perissi V, Staszewski LM, Yang WM, Krones A, Glass CK, Rosenfeld MG, Seto E 2000 The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci USA 97:7202-7207
9. Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, Lazar MA 2000 Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev 14:45-54
10. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
11. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM 1994 Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8:869-884
12. Ogryzko W, Schiltz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959
13. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357
14. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
15. Blanco JC, Minucci S, Lu J, Yang XJ, Walker KK, Chen H, Evans RM, Nakatani Y, Ozato K 1998 The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 12:1638-1651
16. Yang XJ, Ogryzko W, Nishikawa J, Howard BH, Nakatani Y 1996 A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324
17. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
18. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
19. Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW 1997 TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 272:27629-27634
20. Li D, Desai-Yajnik V, Lo E, Schapira M, Abagyan R, Samuels HH 1999 NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol Cell Biol 19:7191-7202
21. Farsetti A, Mitsuhashi T, Desvergne B, Robbins J, Nikodem VM 1991 Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J Biol Chem 266:23226-23232
22. Hodnett DW, Fantozzi DA, Thurmond DC, Klautky SA, MacPhee KG, Estrem ST, Xu G, Goodridge AG 1996 The chicken malic enzyme gene: structural organization and identification of triiodothyronine response elements in the 5′-flanking DNA. Arch Biochem Biophys 334:309-324
23. Muscat GE, Downes M, Dowhan DH 1995 Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family. Bioessays 17:211-218
24. Damjanovski S, Puzianowska-Kuznicka M, Ishuzuya-Oka A, Shi YB 2000 Differential regulation of three thyroid hormone-responsive matrix metalloproteinase genes implicates distinct functions during frog embryogenesis. FASEB J 14:503-510
25. Chin WW, Carr FE, Burnside J, Darling DS 1993 Thyroid hormone regulation of thyrotropin gene expression. Recent Prog Horm Res 48:393-414
26. Lezoualc'h F, Hassan AH, Giraud P, Loeffler JP, Lee SL, Demeneix BA 1992 Assignment of the β-thyroid hormone receptor to 3,5,3′-triiodothyronine-dependent inhibition of transcription from the thyrotropin-releasing hormone promoter in chick hypothalamic neurons. Mol Endocrinol 6:1797-1804
27. Belandia B, Latasa MJ, Villa A, Pascual A 1998 Thyroid hormone negatively regulates the transcriptional activity of the β-amyloid precursor protein gene. J Biol Chem 273:30366-30371
28. Perez-Juste G, Garcia-Silva S, Aranda A 2000 An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J Biol Chem 275:1307-1314
29. Madison LD, Ahlquist JA, Rogers SD, Jameson JL 1993 Negative regulation of the glycoprotein hormone α gene promoter by thyroid hormone: mutagenesis of a proximal receptor binding site preserves transcriptional repression. Mol Cell Endocrinol 94:129-136
30. Chin S, Apriletti J, Gick G 1998 Characterization of a negative thyroid hormone response element in the rat sodium, potassium-adenosine triphosphatase α3 gene promoter. Endocrinology 139:3423-3431
31. Tagami T, Madison LD, Nagaya T, Jameson JL 1997 Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17:2642-2648
32. Tagami T, Park Y, Jameson JL 1999 Mechanisms that mediate negative regulation of the thyroid-stimulating hormone α gene by the thyroid hormone receptor. J Biol Chem 274:22345-22353
33. Sasaki S, Lesoon-Wood LA, Dey A, Kuwata T, Weintraub BD, Humphrey G, Yang WM, Seto E, Yen PM, Howard BH, Ozato K 1999 Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin β gene. EMBO J 18:5389-5398
34. Laflamme L, Hamann G, Messier N, Maltais S, Langlois M-F 2002 RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. J Mol Endocrinol 29:61-72
35. Feng X, Jiang Y, Meltzer P, Yen PM 2000 Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 14:947-955
36. Ahlgren SC, Wallace H, Bishop J, Neophytou C, Raff MC 1997 Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol Cell Neurosci 9:420-432
37. Barres BA, Lazar MA, Raff MC 1994 A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108
38. Paavonen T 1982 Enhancement of human B lymphocyte differentiation in vitro by thyroid hormone. Scan J Immunol 15:211-215
39. Klaushofer K, Varga F, Glantschnig H, Fratzl-Zelman N, Czerwenka E, Leis HJ, Koller K, Peterlik M 1995 The regulatory role of thyroid hormones in bone cell growth and differentiation. J Nutr 125:1996S-2003S
40. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H 1998 The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J 17:4291-4303
41. Su Y, Damjanovski S, Shi Y, Shi YB 1999 Molecular and cellular basis of tissue remodeling during amphibian metamorphosis. Histol Histopathol 14:175-183
42. Rodriguez ER, Tan CD, Onwuta US, Yu ZX, Ferrans VJ, Parrillo JE 1994 3,5,3′-Triiodo-L-thyronine induces cardiac myocyte differentiation but not neuronal differentiation in P19 teratocarcinoma cells in a dose dependent manner. Biochem Biophys Res Commun 205:652-658
43. Edwards MK, McBurney MW 1983 The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol 98:187-191
44. Jones-Villeneuve EM, Rudnicki MA, Harris JF, McBurney MW 1983 Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol 3:2271-2279
45. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA 1998 E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci USA 95:2850-2855
46. Cartwright P, Muller H, Wagener C, Holm K, Helin K 1998 E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17:611-623
47. Johnson DG, Schneider-Broussard R 1998 Role of E2F in cell cycle control and cancer. Front Biosci 3:d447-d448
48. Weintraub SJ, Prater CA, Dean DC 1992 Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261
49. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A 1998 Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605
50. Luo RX, Postigo AA, Dean DC 1998 Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473
51. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T 1998 Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601
52. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP 2000 DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25:338-342
53. Rudnicki MA, McBurney MW 1987 Cell culture methods and induction of differentiation of embryonic carcinoma cell lines. In: Robertson EJ, ed. Teratocarcinomas and embryonic stem cells, a practical approach. Oxford: IRL Press; 19-49
54. Glozak MA, Rogers MB 1996 Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 and BMP4. Dev Biol 179:458-470
55. Slack RS, Hamel PA, Bladon TS, Gill RM, McBurney MW 1993 Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8:1585-1591
56. Durand B, Raff M 2000 A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22:64-71
57. Neuman E, Flemington EK, Sellers WR, Kaelin Jr WG 1994 Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 14:6607-6615
58. Hsiao KM, McMahon SL, Farnham PJ 1994 Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8:1526-1537
59. Johnson DG, Ohtani K, Nevins JR 1994 Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525
60. Wahlström GM, Vennström B, Bondesson M 1999 The adenovirus E1A protein is a potent coactivator for thyroid hormone receptors. Mol Endocrinol 13:1119-1129
61. Williams GR 2000 Cloning and characterization of two novel thyroid hormone receptor β isoforms. Mol Cell Biol 20:8329-8342
62. Wahlström GM, Sjöberg M, Andersson M, Nordström K, Vennström B 1992 Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol 6:1013-1022
63. Taylor AH, Wishart P, Lawless DE, Raymond J, Wong NC 1996 Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein Al promoter. Biochemistry 35:8281-8288
64. Harbers M, Wahlström GM, Vennström B 1998 Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor α. J Steroid Biochem Mol Biol 67:181-191
65. Larsen PR 1989 The pituitary-thyroid regulatory system. Adv Exp Med Biol 261:11-26
66. Azuma-Hara M, Taniura H, Uetsuki T, Niinobe M, Yoshikawa K 1999 Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells. Exp Cell Res 251:442-451
67. Kusek JC, Greene RM, Pisano MM 2001 Expression of the E2F and retinoblastoma families of proteins during neural differentiation. Brain Res Bull 54:187-198
68. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T 2000 Regulation of E2F1 activity by acetylation. EMBO J 19:662-671
69. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T 1995 Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691-694
70. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM 1995 Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698
71. Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH 1999 Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol Cell Biol 19:864-872
72. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY 1994 Heterozygous Rb-1δ20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-1027
73. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A 2002 Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33
74. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J 2002 Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87:1120-1128
75. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, Cohen RN, Wondisford FE 2001 An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98:3998-4003
76. Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B, Rousset B, Weiss R, Trouillas J, Samarut J 1999 Different functions for the thyroid hormone receptors TRα and TRβ in the control of thyroid hormone production and post-natal development. EMBO J 18:623-631
77. Göthe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennström B, Forrest D 1999 Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13:1329-1341
78. Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper ML, Berns A, te Riele H 1992 Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330
79. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, A WR 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
80. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A 1992 Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294
81. Macleod KF, Hu Y, Jacks T 1996 Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 15:6178-6188
82. Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, Morley P, Murray C, Rasquinha I, Slack R, MacManus JP 2000 The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 75:91-100
83. Hou ST, Cowan E, Walker T, Ohan N, Dove M, Rasqinha I, MacManus JP 2001 The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 78:287-297
84. O'Hare MJ, Hou ST, Morris EJ, Cregan SP, Xu Q, Slack RS, Park DS 2000 Induction and modulation of cerebellar granule neuron death by E2F-1. J Biol Chem 275:25358-25364
85. Johnson DG 1995 Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692
86. Sjöberg M, Vennström B 1995 Ligand-dependent and -independent transactivation by thyroid hormone receptor β 2 is determined by the structure of the hormone response element. Mol Cell Biol 15:4718-4726
87. Wood WM, Ocran KW, Gordon DF, Ridgway EC 1991 Isolation and characterization of mouse complementary DNAs encoding α and β thyroid hormone receptors from thyrotrope cells: the mouse pituitary-specific β 2 isoform differs at the amino terminus from the corresponding species from rat pituitary tumor cells. Mol Endocrinol 5:1049-1061
88. Castro DS, Arvidsson M, Bondesson M, Perlmann T 1999 Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2. J Biol Chem 274:37483-37490
89. Helin K, Harlow E, Fattaey A 1993 Transactivation by direct binding of the ritinoblastoma protein. Mol Cell Biol 13:6501-6508
90. Barettino D, Vivanco Ruiz MM, Stunnenberg HG 1994 Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049
91. Horowitz ZD, Yang CR, Forman BM, Casanova J, Samuels HH 1989 Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies. Mol Endocrinol 3:148-156
92. Li Y, Slansky JE, Myers DJ, Drinkwater NR, Kaelin WG, Farnham PJ 1994 Cloning, chromosomal location, and characterization of mouse E2F1. Mol Cell Biol 14:1861-1869
93. Andersson ML, Vennström B 2000 A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site. Oncogene 19:3563-3569
94. Samuels HH, Stanley F, Casanova J 1979 Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80-85
95. Tokumoto YM, Tang DG, Raff MC 2001 Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J 20:5261-5268